Atlas Trials

Chronic Myelomonocytic Leukemia (CMML)

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Chronic Myelomonocytic Leukemia (CMML)

RecordFirmDate
Pharmacokinetics, Tolerability and Safety of NEX-18a (NCT05048498)Nanexa AB2021-04-27
Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations (NCT04409639)University of Utah2021-01-12
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations (NCT04603001)Eli Lilly and Company2020-11-19
SNS-301 Monotherapy in High Risk MDS and CMML (NCT04217720)Sensei Biotherapeutics, Inc.2020-04-01
Study of NMS-03592088 in Patients With Relapsed or Refractory AML or CMML (NCT03922100)Nerviano Medical Sciences2019-04-03
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN (NCT03613532)Jacqueline Garcia, MD2018-10-24
Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome (NCT02749708)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2017-01-30
Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML) (NCT02546284)Humanigen, Inc.2016-07-01
Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL (NCT02147873)TetraLogic Pharmaceuticals2014-06-01
Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS) (NCT01842646)H. Lee Moffitt Cancer Center and Research Institute2013-08-29
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) (NCT01736683)Merck Sharp & Dohme LLC2012-11-28
A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients (NCT01613976)Novartis Pharmaceuticals2012-08-01
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia (NCT00528983)Celgene2007-09-11
Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia (NCT00664677)Erimos Pharmaceuticals2007-08-01

Track Chronic Myelomonocytic Leukemia (CMML) automatically

Every clearance here is in the API, with alerts when new ones post.